FURLAN, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 849
EU - Europa 685
AS - Asia 117
AF - Africa 3
SA - Sud America 1
Totale 1.655
Nazione #
US - Stati Uniti d'America 844
SE - Svezia 423
IT - Italia 123
CN - Cina 75
FI - Finlandia 40
IE - Irlanda 34
GB - Regno Unito 28
DE - Germania 25
IN - India 11
JP - Giappone 8
SA - Arabia Saudita 5
SG - Singapore 5
CA - Canada 4
IR - Iran 4
EG - Egitto 3
FR - Francia 3
NL - Olanda 3
HK - Hong Kong 2
KR - Corea 2
PK - Pakistan 2
PL - Polonia 2
BR - Brasile 1
ES - Italia 1
GR - Grecia 1
ID - Indonesia 1
JO - Giordania 1
MX - Messico 1
RU - Federazione Russa 1
TR - Turchia 1
UA - Ucraina 1
Totale 1.655
Città #
Lawrence 174
Princeton 172
Ashburn 161
Milan 63
New York 52
Shanghai 52
Washington 40
Helsinki 37
Dublin 34
Los Angeles 15
Seattle 15
Manchester 11
Pune 7
Rome 6
Austin 5
Jeddah 5
London 5
Borås 4
Edgware 4
Harrow 4
Kunming 4
Chions 3
Lappeenranta 3
Qina 3
Beijing 2
Bergamo 2
Canneto sull'Oglio 2
Central 2
Chandigarh 2
Chaponnay 2
Chuo 2
Florence 2
Karachi 2
Naples 2
Salford 2
San Mateo 2
Santa Clara 2
Shinjuku 2
's-Hertogenbosch 1
Andover 1
Arenzano 1
Belleville 1
Berlin 1
Boardman 1
Brierley Hill 1
Carate Brianza 1
Cassolnovo 1
Castel Maggiore 1
Cheongju-si 1
Duncan 1
Ely 1
Enschede 1
Erlangen 1
Falkenstein 1
Genoa 1
Giulianova 1
Gunzenhausen 1
Gurgaon 1
Halifax 1
Houston 1
Indore 1
Kish 1
Leganés 1
Melikgazi 1
Mexico City 1
Montesilvano 1
Mount Vernon 1
Mountain View 1
Napoli 1
Nuremberg 1
Offenbach 1
Redmond 1
Redwood City 1
Rouyn-Noranda 1
Segrate 1
Tehran 1
Temecula 1
Toronto 1
Vaprio d'Adda 1
Verona 1
Vinnytsia 1
Voghera 1
Zanjan 1
Zola Predosa 1
Totale 953
Nome #
Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up 33
Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study 29
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 27
A peripheral inflammatory signature discriminates bipolar from unipolar depression: A machine learning approach 25
One-year mental health outcomes in a cohort of COVID-19 survivors 21
Clinical Features and Biomarkers to Differentiate Primary and Amyotrophic Lateral Sclerosis in Patients With an Upper Motor Neuron Syndrome 19
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 19
Neuroinflammation in Bipolar Depression 19
Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder 18
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients 18
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 17
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study 17
Neurofilaments light: Possible biomarker of brain modifications in bipolar disorder 17
INCREASE OF MYELOID MICROVESICLES IN THE CEREBROSPINAL FLUID AS BIOMARKER OF MICROGLIA/MACROPHAGE ACTIVATION IN NEUROLOGICAL DISORDERS 16
Dysregulation of MS risk genes and pathways at distinct stages of disease 16
Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis 16
Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life 16
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 15
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 15
DIFFERENTIAL miRNAs EXPRESSION PROFILE BETWEEN TREG-VERSUS T EFFECTOR CELLS IN COURSE OF MULTIPLE SCLEROSIS 15
Cytokines and immunity in multiple sclerosis: the dual signal hypothesis 15
MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis 15
Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis 15
Mood-congruent negative thinking styles and cognitive vulnerability in depressed COVID-19 survivors: A comparison with major depressive disorder 15
Gene transfer to pancreatic islets mediated by a replication incompetent HSV-1 14
Absence of oligoclonally restricted immunoglobulins in tears from multiple sclerosis patients 14
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 14
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicantre study 14
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 14
AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis 14
Administration of an MCP-1 variant to EAE mice prevents inflammatory cell recruitment and protects from demyelination and axonal loss 13
Classical and unconventional pathways of vesicular release in microglia 13
A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis 13
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice 13
T regulatory cells are markers of disease activity in multiple sclerosis patients 13
A gene therapy approach to treat demyelinating diseases using nonreplicative herpetic vectors engineered to produce cytokines 13
Natural Killer cells protect white matter integrity in Bipolar Disorder 13
Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis 13
CSF extracellular vesicles and risk of disease activity after a first demyelinating event 13
Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors 13
ACID SPHINGOMYELINASE TRIGGERS P2X7-INDUCED MICROPARTICLE RELEASE FROM GLIAL CELLS 12
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach 12
Cxcl10 enhances blood cells migration in the sub-ventricular zone of mice affected by experimental autoimmune encephalomyelitis 12
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes. 12
Stiff-man syndrome and autoimmunity; pathogenetic problems 12
Real time RT-PCR determination of mRNA levels of cytokine, chemokine and chemokine receptors in PBLs from MS patients: clinical and MRI correlations 12
Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients 12
Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis 12
Plasma neurofilament light chain levels and cognitive testing as predictors of fast progression in Alzheimer’s disease 12
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects 11
Neuromyelitis optica spectrum disorder: the importance of NMO-IgG in clinical practice 11
Lentiviral-mediated administration of IL-25 in the CNS induces alternative activation of microglia 11
Vitamin D levels and risk of developing multiple sclerosis 11
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica 11
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression 11
Mesenchymal stem cells as treatment for multiple sclerosis: Immunomodulation versus tissue repair 10
Motor-evoked potentials (MEPs) for monitoring chronic cortico-spinal damage in MOG35-55-induced experimental autoimmune encephalomyelitis (EAE) 10
ALTERED MRNA LEVELS OF CHEMOKINES AND CYTOKINES IN SCHIZOPHRENIA AND BIPOLAR DISORDER 10
Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndrome 10
Subclinical central inflammation is risk for RIS and CIS conversion to MS 10
Neural progenitor cells orchestrate microglia migration and positioning into the developing cortex 10
Activation of invariant NKT cells by alpha GalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma 10
Cytokine gene delivery into the central nervous system using intrathecally injected non-replicative viral vectors 10
Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis 10
Activated macrophages release microvesicles containing polarized M1 or M2 mRNAs 10
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates 10
miR-21 sustains CD28 signalling and low-affinity T-cell responses at the expense of self-tolerance 10
COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: A 2-year study 10
Evaluation of different techniques to detect anti-acquaporin 4 antibodies in neuromyelitis optica patients 9
Method for intracellular labeling of lymphocytes using Endorem(R) and Feridex(R): Possible applications for MRI studies in multiple sclerosis (MS) 9
In vivo fate analysis reveals the multipotent and self-renewal features of embryonic AspM expressing cells 9
Similar low frequency of anit-MOG IgG and IgM in MS patients and healthy subjects 9
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 9
Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment. 9
Artificial intelligence techniques in the diagnosis of multiple sclerosis 9
Animal models of multiple sclerosis 9
Central Nervous system delivery of Interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination 9
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis 9
Synapsin I deletion reduces neuronal damage and ameliorates clinical progression of experimental autoimmune encephalomyelitis 9
Prognostic Value of Vitamin D in Clinically Isolated Syndromes (CIS) 9
Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients 9
Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis 9
LONG-TERM DISEASE CONTROL OF REFRACTORY NEUROMYELITIS OPTICA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 9
Diagnostic value of IgG4 Indices in IgG4-related hypertrophic pachymeningitis. 9
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes 9
The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms 8
Opposite changes of glutamate and GABA transmission in the striatum of mice with experimental autoimmune encephalomyelitis 8
Inflammation affects striatal glutamate transmission since the pre-clinical phase of experimental autoimmune encephallonlyelitis 8
Clinical and functional recovery from experimental autoimmune encephalomyelitis by intracisternal delivery of IL4 from a helper-dependent adenoviral vector. A pre-clinical model of gene therapy of multiple sclerosis 8
Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients 8
MICROVESICLES IN THE CEREBROSPINAL FLUID REFLECT MICROGLIA/MACROPHAGE ACTIVATION IN RODENT AND HUMAN NEURO-INFLAMMATION 8
MICROGLIAL MICROPARTICLES AS POTENTIAL BIOMARKER FOR NEUROINFLAMMATORY AND NEURODEGENERATIVE DISEASES 8
Acid sphingomyelinase activity triggers microparticle release from glial cells 8
Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination 8
Ventilation With Argon Improves Survival With Good Neurological Recovery After Prolonged Untreated Cardiac Arrest in Pigs 8
Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis 8
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice 8
Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study 8
Cannabinoid CB1 receptors regulate neuronal TNF-alpha effects in experimental autoimmune encephalomyelitis 8
Myeloid microvescicles as potential biomarers of disease progression in dementia patients 8
Totale 1.239
Categoria #
all - tutte 35.032
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.032


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 5 1 0 0 0 0 0 0 0 6 0 1
2020/202118 0 0 0 3 0 0 5 0 8 0 2 0
2021/2022162 6 4 1 57 14 18 16 5 7 15 7 12
2022/20231.070 398 175 50 6 8 85 37 49 28 24 201 9
2023/2024643 7 44 108 61 103 174 20 62 8 26 30 0
Totale 1.959